Mark SmithMark Smith 将于202012月1作为 Director 加入公司 (新闻发布的2020十一月17号).
Jennifer CookJennifer Cook 将于202012月1作为 Director 加入公司 (新闻发布的2020十一月17号).
Jennifer CookJennifer Cook 将于202012月1作为 Director 加入公司 (新闻发布的2020十一月17号).
创建提醒
跟踪 Jazz Pharmaceuticals 的高管变动
Canopy Growth has announced the acquisition of Supreme Cannabis (posted on 4月 9, 2021).
Eloxx Pharmaceuticals has acquired Zikani Therapeutics (posted on 4月 5, 2021).
Servier Pharmaceuticals has announced the acquisition of Agios Pharmaceuticals (posted on 4月 5, 2021).
Jazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Study in Cataplexy or Excessive Daytime Sleepiness in Patients with Narcolepsy | Jazz Pharmaceuticals plc
Jazz Pharmaceuticals to Report 2020 Third Quarter Financial Results on November 2, 2020 | Jazz Pharmaceuticals plc
Jazz Pharmaceuticals Announces Webcast for Xywav Investor Update | Jazz Pharmaceuticals plc
New Data for Zepzelca™ (lurbinectedin) to be Presented at IASLC 2020 North America Conference on Lung Cancer | Jazz Pharmaceuticals plc
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia | Jazz Pharmaceuticals plc
Jazz Pharmaceuticals 在 维基百科、谷歌新闻 和 雅虎财经
Jazz Pharmaceuticals 在 LinkedIn、叽叽喳喳 和 YouTube
Jazz Pharmaceuticals 拥有 3 家子公司,其中包括 Eusa Pharma、Jazz Pharmaceuticals Europe 和 Jazz Pharmaceuticals Iberia。 Jazz Pharmaceuticals 拥有 2,064 家竞争者,其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。